Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy.

MLA

Williams, Scott G., et al. “Factors Predicting for Urinary Morbidity Following 125iodine Transperineal Prostate Brachytherapy.” Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, vol. 73, no. 1, Oct. 2004, pp. 33–38. EBSCOhost, https://doi.org/10.1016/j.radonc.2004.07.026.

APA

Williams, S. G., Millar, J. L., Duchesne, G. M., Dally, M. J., Royce, P. L., & Snow, R. M. (2004). Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy. Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology, 73(1), 33–38. https://doi.org/10.1016/j.radonc.2004.07.026

Chicago

Williams, Scott G, Jeremy L Millar, Gillian M Duchesne, Michael J Dally, Peter L Royce, and Ross M Snow. 2004. “Factors Predicting for Urinary Morbidity Following 125iodine Transperineal Prostate Brachytherapy.” Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology 73 (1): 33–38. doi:10.1016/j.radonc.2004.07.026.